Latest News for Sudo Biosciences

News

Latest Press Releases

Dec 2, 2024

Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550

Feb 13, 2024

Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M

Dec 20, 2023

Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the Clinic

View All Press Releases

Latest News Articles

Endpoints News | Dec 20, 2023

Exclusive: Sudo Biosciences secures $116M to start trials of its oral and topical TYK2 candidates

Fierce Biotech | Dec 20, 2023

Sanofi-backed Sudo scores $116M for TYK2 MS, psoriasis candidates

Pharma Letter | Dec 20, 2023

Sudo Biosciences raises $116 million in Series B financing

View All News Articles